Reducing human suffering by detecting cancer earlier with patented technology

BioCurex's RECAF(tm) marker is found in all types of major cancers

Hub Home

> Log In

Demo Video
Private Messages
Edit My Profile
View/Edit Portfolio

Email Updates

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

Aim to develop and manufacture the best technology graphite in the world
Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More | *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013 Read More | *SPONSOR

Message: Big Cancer Bill Aims to Increase Biomarker Research and Use

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

Half Full Glass

Rank: [?]

Vice President

Points: [?]

1181

Rating: [?]

Votes: 15 Score: 3.6

Currently 3.6/5 Stars.

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Big Cancer Bill Aims to Increase Biomarker Research and Use

posted on Apr 14, 09 06:30PM

Monday, March 30, 2009

Big Cancer Bill Aims to Increase Biomarker Research and Use - U.S.

"ALERT (Act) also would have NCI report annually on its plans and progress regarding research on cancers with low incidence and survival rates, and would establish a grants program to conduct research on such cancers.

Among other measures, the act also would establish a grant program for the states that would fund colorectal cancer screening and referrals for medical treatment that is similar to the national breast and cervical cancer programs.

The bill also includes a number of measures and programs aimed at the issues surrounding patients and health insurance coverage, including a provision that would enable patients to continue to receive coverage for treatment while they are in clinical trials."

Posted by Sandi Pniauskas at Monday, March 30, 2009

http://ovariancancerandus.blogspot.c...

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

New Message

Please login to post a reply

Agoracom TV

Check out Agoracom's daily, fast-paced, newscast on the morning's top Small-Cap newsmakers

Mesh With Us On The Web's Top Social Networking Sites

Find Our Content Throughout The Web With Our New Media Partners

AGORACOM Quick Tips

Small-Cap CEO Lessons - Is Your CEO Out Of Touch? ... Not Anymore

Click To Watch Today's Show

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote

Open BOCX Stock Quote

Investment Ideas

Like BioCurex? Then you might also be interested in Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd.

Developer of the TERRASTARTM in-flight safety monitoring system
The first system in the world to feature real-time in-flight data monitoring and diagnostics
echnical Partnership Agreement with Astrium, a wholly owned subsidiary of EADS

Agoracom